Drugs and autoimmunity--a contemporary review and mechanistic approach.
about
In vitro Models to Evaluate Drug-Induced Hypersensitivity: Potential Test Based on Activation of Dendritic CellsOrganic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysisHapten-induced contact hypersensitivity, autoimmune reactions, and tumor regression: plausibility of mediating antitumor immunityEpidemiology of environmental exposures and human autoimmune diseases: findings from a National Institute of Environmental Health Sciences Expert Panel WorkshopUsing gene expression signatures to identify novel treatment strategies in gulf war illnessPathogenesis of systemic lupus erythematosus revisited 2011: end organ resistance to damage, autoantibody initiation and diversification, and HLA-DR.Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.Autoimmunity and environment: am I at risk?Liver immunology.Arthritis and benznidazole: more closely related than we thought.Environment, autoantibodies, and autoimmunityTo B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice.Autoantibodies with enzymatic properties in human autoimmune diseases.Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedsideGender differences in autoimmunity associated with exposure to environmental factors[Systemic lupus erythematosus induced by isoniazid: a rare complication to fear].Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.Criteria for environmentally associated autoimmune diseases.Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agentsAntimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosisBiogenic selenium nanoparticles: characterization, antimicrobial activity and effects on human dendritic cells and fibroblasts.Demographic associations for autoantibodies in disease-free individuals of a European population.Celiac disease: a model disease for gene-environment interaction.Perspectives on epigenetics and its relevance to adverse drug reactions.Drug-induced lupus erythematosus: incidence, management and prevention.Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic miceHypersensitivity reactions to corticosteroids.Epigenetics changes associated to environmental triggers in autoimmunity.Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity.T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1.Cytotoxic Activity of Highly Purified Silver Nanoparticles Sol Against Cells of Human Immune System.Explosion of autoimmune diseases and the mosaic of old and novel factors.Epigenetic alterations and autoimmune disease.The future of autoimmunity.Autoimmune signals in non-segmental vitiligo patients are associated with distinct clinical parameters and toxic exposures.Geographical differences in autoantibodies and anti-infectious agents antibodies among healthy adults.Cutting-edge issues in organ-specific autoimmunity.Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database.Associations between Antibiotics for Non-tuberculous Mycobacterial Infection and Incident Sjögren's Syndrome: A Nationwide, Population-based Case-control Study
P2860
Q26741420-D3BB7A7E-D656-4A11-8E6E-388A70EB35E6Q26860327-B00B6558-14F5-4E11-8EAD-82F6CD3D1D13Q28387629-6FFBD56E-FBC2-4781-AA7D-4691EDCFC4F0Q28390922-F9352742-EABE-405D-A159-3EAECA45DEE7Q28397964-B4F8BE34-5F4E-4DA8-AF99-7607D7939249Q30425180-467741A4-CD63-4CD4-80D7-0F3CAF716ED1Q31034415-84807C0B-E6EE-4DC7-B801-6E9BAC57FB5BQ33825348-93FCAD24-AFE1-4A97-853A-93C8D3EB03ABQ34359990-EF9B9AD8-E6C9-4B54-A936-2300C63FDBAEQ34923301-EB7496BE-EE2C-4AAA-8ED8-9F8059E07730Q35071854-B686F34C-6B60-457D-8CF6-0B909B4DFEB7Q35214196-4CE8257A-8800-447E-9423-9CE837FCB4A0Q35214200-0ABDBFD4-6227-449E-AB06-A03A192CAD06Q35309470-7C4A173E-F5DA-4C05-AB58-8983E3ACD9B7Q35827986-7C2BF86D-64D6-4072-A0CC-0910624D11B4Q36080421-664FC945-DD0F-49C7-8B6B-C50DD36D830AQ36237416-DA3CB2AA-F699-452C-B5E5-D80EA96ADAA6Q36310013-3ECECC7A-C9BE-45A2-80A0-938C678E7A46Q36579988-BB18995A-E649-490B-8425-534C51919D49Q36696219-F00F25D9-5B95-4127-B7AD-1613D0EBEAB8Q37353486-9A0A4595-97EE-43BE-B31C-EAAF4136B8BFQ37723988-EFD05549-4A55-4A78-A33A-07D7E6A63062Q37841101-3A75BF76-8307-4E02-A2BD-386098EF0C47Q37867482-A8F86972-3844-48E7-8303-E3CBF5003C35Q37868002-B3785CC2-6481-46B0-920B-451BA5A7E342Q37883681-21CABBD9-BE11-475F-9C21-4398E62A4243Q38097320-003EEA15-ECC5-4CCC-8280-87429D5E6046Q38586605-4FC311E5-F779-4233-AB3B-93EB4FACBA70Q38905591-36F13361-D4F7-4B77-950D-2A12874A968DQ39515619-500D560E-711D-45E3-AF87-2D4E5EF8F7C7Q41444937-E4DFA2E7-4293-4B81-928E-6187E67DF9D8Q42558630-79D1462F-C595-47FA-B719-5D6665AC9920Q43522609-8DDB71E9-592C-44CF-B622-7E48528E12EFQ43786536-6B120939-33F5-414B-9926-315191A857B9Q45826321-019F3496-E87D-429F-BF31-7C05F6856784Q45932087-198FBE29-D486-4114-AB58-E2CBA46B03C7Q45959876-3DDC17D7-14BB-4D0E-AD38-E4323AFB5E19Q51136025-A9355DA6-518E-4E95-96C0-FB00A450C8F6Q58098872-13210B8D-1640-4CCE-90D5-171089DA963C
P2860
Drugs and autoimmunity--a contemporary review and mechanistic approach.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drugs and autoimmunity--a contemporary review and mechanistic approach.
@en
Drugs and autoimmunity--a contemporary review and mechanistic approach.
@nl
type
label
Drugs and autoimmunity--a contemporary review and mechanistic approach.
@en
Drugs and autoimmunity--a contemporary review and mechanistic approach.
@nl
prefLabel
Drugs and autoimmunity--a contemporary review and mechanistic approach.
@en
Drugs and autoimmunity--a contemporary review and mechanistic approach.
@nl
P1476
Drugs and autoimmunity--a contemporary review and mechanistic approach.
@en
P2093
Christopher Chang
P304
P356
10.1016/J.JAUT.2009.11.012
P577
2009-12-16T00:00:00Z